Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Breddin

Showing results (161-170 of 213) with videos related to

Pageof 22
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|May 9, 2002
Effects of antiplatelet agents on platelet-induced thrombin generationW Wegert, J Graff, D Kaiser, et al.
Thrombosis and Haemostasis|May 6, 1991
Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex--1. Glycoprotein analysisM Meyer, C M Kirchmaier, A Schirmer, et al.
British Journal of Clinical Pharmacology|April 12, 2000
Interaction between the LMWH reviparin and aspirin in healthy volunteersU Klinkhardt, H K Breddin, H U Esslinger, et al.
Haemostasis|January 1, 1992
Platelet-induced thrombin generation time: a new sensitive global assay for platelet function and coagulation. Method and first resultsM Basic-Micic, C Roman, U Herpel, et al.
Seminars in Thrombosis and Hemostasis|October 23, 2001
Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparinJ Harenberg, M V Huisman, A R Tolle, et al.
Arzneimittel-Forschung|September 1, 1995
Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregationU Windscheif, P Radziwon, H K Breddin, et al.
Thrombosis and Haemostasis|February 8, 2003
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosisHans K Breddin, Zbigniew Kadziola, Mike Scully, et al.
Haemostasis|January 1, 1991
Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis modelC Doutremepuich, M C Lalanne, F Doutremepuich, et al.
Progress in Clinical and Biological Research|January 1, 1989
Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention?U Till, I Bergmann, K Breddin, et al.
Haemostasis|July 1, 1996
A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation timeJ F Schenk, E Glusa, P Radziwon, et al.
Pageof 22

Showing results (161-170 of 213) with videos related to

Sort By:
Pageof 22
International Journal of Clinical Pharmacology and Therapeutics|May 9, 2002
Effects of antiplatelet agents on platelet-induced thrombin generationW Wegert, J Graff, D Kaiser, et al.
Thrombosis and Haemostasis|May 6, 1991
Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex--1. Glycoprotein analysisM Meyer, C M Kirchmaier, A Schirmer, et al.
British Journal of Clinical Pharmacology|April 12, 2000
Interaction between the LMWH reviparin and aspirin in healthy volunteersU Klinkhardt, H K Breddin, H U Esslinger, et al.
Haemostasis|January 1, 1992
Platelet-induced thrombin generation time: a new sensitive global assay for platelet function and coagulation. Method and first resultsM Basic-Micic, C Roman, U Herpel, et al.
Seminars in Thrombosis and Hemostasis|October 23, 2001
Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparinJ Harenberg, M V Huisman, A R Tolle, et al.
Arzneimittel-Forschung|September 1, 1995
Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregationU Windscheif, P Radziwon, H K Breddin, et al.
Thrombosis and Haemostasis|February 8, 2003
Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosisHans K Breddin, Zbigniew Kadziola, Mike Scully, et al.
Haemostasis|January 1, 1991
Comparative study of three recombinant hirudins with heparin in an experimental venous thrombosis modelC Doutremepuich, M C Lalanne, F Doutremepuich, et al.
Progress in Clinical and Biological Research|January 1, 1989
Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention?U Till, I Bergmann, K Breddin, et al.
Haemostasis|July 1, 1996
A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation timeJ F Schenk, E Glusa, P Radziwon, et al.
Pageof 22